145 related articles for article (PubMed ID: 17119067)
1. Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer.
Martin YN; Olson JE; Ingle JN; Vierkant RA; Fredericksen ZS; Pankratz VS; Wu Y; Schaid DJ; Sellers TA; Weinshilboum RM
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2322-4. PubMed ID: 17119067
[No Abstract] [Full Text] [Related]
2. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
3. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany.
Justenhoven C; Hamann U; Pierl CB; Rabstein S; Pesch B; Harth V; Baisch C; Vollmert C; Illig T; Brüning T; Ko Y; Brauch H
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):3015-8. PubMed ID: 16365030
[No Abstract] [Full Text] [Related]
4. Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer.
Cam R; Eroglu A; Egin Y; Akar N
Breast Cancer Res Treat; 2009 May; 115(2):431-2. PubMed ID: 18498051
[No Abstract] [Full Text] [Related]
5. p53 genotypes and haplotypes associated with risk of breast cancer.
Buyru N; Altinisik J; Demokan S; Dalay N
Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
[TBL] [Abstract][Full Text] [Related]
6. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
7. Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?
Singh V; Parmar D; Singh MP
Cancer Invest; 2008 Oct; 26(8):769-83. PubMed ID: 18798070
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Langsenlehner T; Renner W; Yazdani-Biuki B; Langsenlehner U
Breast Cancer Res Treat; 2008 Feb; 107(3):459-60. PubMed ID: 17453338
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of methylenetetrahydrofolate reductase and risk of aggressive behaviour in schizophrenia.
Dong ZQ; Tian YY; Guan X; Wu J; Gu Y; Hu ZQ; Sun XL
Psychiatry Res; 2012 Dec; 200(2-3):1082. PubMed ID: 22917961
[No Abstract] [Full Text] [Related]
11. Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population--implications for association study design and clinical genetic testing services.
Dissanayake VH; Weerasekera LY; Gammulla CG; Jayasekara RW
Exp Mol Pathol; 2009 Oct; 87(2):159-62. PubMed ID: 19591822
[TBL] [Abstract][Full Text] [Related]
12. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
13. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
15. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
[TBL] [Abstract][Full Text] [Related]
16. Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population.
Shekari M; Sobti RC; Kordi Tamandani DM; Suri V
Arch Gynecol Obstet; 2008 Dec; 278(6):517-24. PubMed ID: 18351371
[TBL] [Abstract][Full Text] [Related]
17. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.
Pepe C; Guidugli L; Sensi E; Aretini P; D'Andrea E; Montagna M; Manoukian S; Ottini L; Radice P; Viel A; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2007 May; 103(1):29-36. PubMed ID: 17151928
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.
Muntjewerff JW; Gellekink H; den Heijer M; Hoogendoorn ML; Kahn RS; Sinke RJ; Blom HJ
Eur Neuropsychopharmacol; 2008 Feb; 18(2):99-106. PubMed ID: 17716874
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of MTHFR gene associated with livedoid vasculopathy in Taiwanese population.
Tsai TF; Yang CH; Chu CY; Liou YH; Hsiao WC; Lin CT; Wu LS
J Dermatol Sci; 2009 Jun; 54(3):214-6. PubMed ID: 19167867
[No Abstract] [Full Text] [Related]
20. [Study on the association of polymorphisms in homocysteine metabolism related enzymes with deep venous thrombosis].
Yu HD; Zheng H; Qi H; Lian JH; He Y; Dong ZM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):635-9. PubMed ID: 17160942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
